0001209191-17-063687.txt : 20171204 0001209191-17-063687.hdr.sgml : 20171204 20171204202303 ACCESSION NUMBER: 0001209191-17-063687 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171130 FILED AS OF DATE: 20171204 DATE AS OF CHANGE: 20171204 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Routti Jorma CENTRAL INDEX KEY: 0001621330 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 171238466 MAIL ADDRESS: STREET 1: C/O FIBROGEN, INC. STREET 2: 409 ILLINOIS ST., CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-11-30 0 0000921299 FIBROGEN INC FGEN 0001621330 Routti Jorma C/O FIBROGEN, INC. 409 ILLINOIS ST. SAN FRANCISCO CA 94158 1 0 0 0 Common Stock 2017-11-30 4 M 0 6000 2.90 A 133840 D Common Stock 2017-11-30 4 S 0 6000 47.18 D 127840 D Common Stock 2017-12-01 4 M 0 6000 2.90 A 133840 D Common Stock 2017-12-01 4 S 0 6000 47.32 D 127840 D Stock Option (Right to Buy) 2.90 2017-11-30 4 M 0 6000 0.00 D 2020-06-09 Common Stock 6000 6000 D Stock Option (Right to Buy) 2.90 2017-12-01 4 M 0 6000 0.00 D 2020-06-09 Common Stock 6000 0 D Shares sold pursuant to a 10b5-1 plan. The shares were sold at prices ranging from $46.80 to $47.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $47.00 to $47.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price Fully vested. /s/ Dorothy Pacini, Attorney-in-fact 2017-12-04